199 related articles for article (PubMed ID: 10665466)
21. Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder.
Karve S; Markowitz M; Fu DJ; Lindenmayer JP; Wang CC; Candrilli SD; Alphs L
Appl Health Econ Health Policy; 2014 Jun; 12(3):335-46. PubMed ID: 24756319
[TBL] [Abstract][Full Text] [Related]
22. Six-month outcome following a relapse of schizophrenia.
Bergen J; Hunt G; Armitage P; Bashir M
Aust N Z J Psychiatry; 1998 Dec; 32(6):815-22. PubMed ID: 10084346
[TBL] [Abstract][Full Text] [Related]
23. Characteristics, diagnoses and risk profiles of inpatients readmitted within 28 days of discharge to an Australian private psychiatric hospital.
Keks NA; Hope J; Adamopoulos V; Pring W; Tofler D; Macfarlane S; Van Sebille D
Australas Psychiatry; 2020 Jun; 28(3):311-321. PubMed ID: 32019356
[TBL] [Abstract][Full Text] [Related]
24. Readmission in psychiatry inpatients within a year of discharge: The role of symptoms at discharge and post-discharge care in a Brazilian sample.
Baeza FLC; da Rocha NS; Fleck MPA
Gen Hosp Psychiatry; 2018; 51():63-70. PubMed ID: 29324277
[TBL] [Abstract][Full Text] [Related]
25. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
[TBL] [Abstract][Full Text] [Related]
26. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
Taylor D; Hayhurst K; Kerwin R
Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and social risk factors for the readmission of patients with schizophrenia to psychiatric inpatient care: a long-term analysis].
Warnke I; Nordt C; Ajdacic-Gross V; Haug A; Salize HJ; Rössler W
Neuropsychiatr; 2010; 24(4):243-51. PubMed ID: 21176705
[TBL] [Abstract][Full Text] [Related]
28. Choosing antipsychotic maintenance therapy--a naturalistic study.
Tavcar R; Dernovsek MZ; Zvan V
Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
[TBL] [Abstract][Full Text] [Related]
29. Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia.
Leatherman SM; Liang MH; Krystal JH; Lew RA; Valley D; Thwin SS; Rosenheck RA;
J Nerv Ment Dis; 2014 Jan; 202(1):13-7. PubMed ID: 24375206
[TBL] [Abstract][Full Text] [Related]
30. Is the substance abuse of inpatients with schizophrenia overlooked?
Walkup JT; McAlpine DD; Olfson M; Labay L; Boyer CA; Hansell S
Gen Hosp Psychiatry; 2001; 23(1):26-30. PubMed ID: 11226554
[TBL] [Abstract][Full Text] [Related]
31. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.
Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM
Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277
[TBL] [Abstract][Full Text] [Related]
32. Incarceration and hospital care.
Prince JD
J Nerv Ment Dis; 2006 Jan; 194(1):34-9. PubMed ID: 16462553
[TBL] [Abstract][Full Text] [Related]
33. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
[TBL] [Abstract][Full Text] [Related]
34. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide.
Harkavy-Friedman JM; Restifo K; Malaspina D; Kaufmann CA; Amador XF; Yale SA; Gorman JM
Am J Psychiatry; 1999 Aug; 156(8):1276-8. PubMed ID: 10450275
[TBL] [Abstract][Full Text] [Related]
35. Intensity of outpatient monitoring after discharge and psychiatric rehospitalization of veterans with depression.
Kim HM; Pfeiffer P; Ganoczy D; Valenstein M
Psychiatr Serv; 2011 Nov; 62(11):1346-52. PubMed ID: 22211215
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for early readmission to acute care for persons with schizophrenia taking antipsychotic medications.
Boaz TL; Becker MA; Andel R; Van Dorn RA; Choi J; Sikirica M
Psychiatr Serv; 2013 Dec; 64(12):1225-9. PubMed ID: 23945797
[TBL] [Abstract][Full Text] [Related]
37. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
[TBL] [Abstract][Full Text] [Related]
38. Medication adherence among psychotic patients before admission to inpatient treatment.
Rittmannsberger H; Pachinger T; Keppelmüller P; Wancata J
Psychiatr Serv; 2004 Feb; 55(2):174-9. PubMed ID: 14762243
[TBL] [Abstract][Full Text] [Related]
39. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
Diaz E; Levine HB; Sullivan MC; Sernyak MJ; Hawkins KA; Cramer JA; Woods SW
J Psychiatry Neurosci; 2001 Sep; 26(4):325-9. PubMed ID: 11590972
[TBL] [Abstract][Full Text] [Related]
40. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
